China Dongxiang (03818) saw its shares surge over 16% in afternoon trading, reaching an increase of 10.42% to HKD 0.53, with a trading volume of HKD 34.2039 million as of the time of this report. Traditionally, China Dongxiang announces its mid-year results in November, and it is anticipated that the company will disclose its interim financial report ending September this year. The full-year results released in June indicated that the company’s investment division generated a net income of HKD 271 million, a remarkable turnaround from a loss of HKD 724 million in the same period last year. Overall, while revenue in the sportswear business showed some fluctuations, the recovery in investment income and strict control of operating costs have led to an improvement in the company's financial health. Public information reveals that through collaborations with renowned investment firms such as Yunfeng Capital, Fosun Capital, and CPE Yuanfeng (formerly CITIC Industry Fund), China Dongxiang's investment areas encompass high-tech industries, financial services, new energy, and healthcare, which are all popular sectors for primary equity investments. In addition to Yunfeng Capital, Sequoia Capital China is another key partner closely collaborating with China Dongxiang.